Skip to main content
Mukka Proteins Limited logo

Mukka Proteins Limited — Investor Relations & Filings

Ticker · MUKKA ISIN · INE0CG401037 LEI · 3358001F6BWKSFSZ2U02 BSE.NS Manufacturing
Filings indexed 220 across all filing types
Latest filing 2025-11-14 Regulatory Filings
Country IN India
Listing BSE.NS MUKKA

About Mukka Proteins Limited

https://mukkaproteins.com/

Mukka Proteins Limited specializes in the manufacture and supply of high-quality fish meal, fish oil, and fish soluble paste. The company serves as a critical supplier to the global aquafeed, poultry feed, and pet food sectors. Its core operations involve processing raw fish into nutrient-dense protein sources and essential fatty acids, including Omega-3. The product portfolio includes steam-dried fish meal and high-grade fish oil used in specialized animal nutrition formulations. Mukka Proteins maintains a robust supply chain and utilizes advanced processing technologies to ensure product consistency and nutritional integrity. The company caters to both domestic and international markets, positioning itself as a key provider of sustainable marine protein ingredients for the livestock and aquaculture sectors.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a newspaper advertisement pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing unaudited financial results for the quarter and half year ended 30th September 2025. It includes extracts of unaudited standalone and consolidated financial results, approved by the Board of Directors, and mentions that the full financial results and limited review report are available on the company's and stock exchanges' websites. The document is about the publication of financial results in newspapers and provides summary financial data but does not contain the full detailed financial report itself. It is a formal announcement of financial results publication rather than the full interim or quarterly report. Therefore, it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication and not the full report itself. The document length is 15,000 characters, which is substantial but the content is primarily an announcement and extract, not a full financial report with detailed analysis and statements. Hence, the classification is Regulatory Filings (RNS) with high confidence.
2025-11-14 English
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the renewal of Consent For Operation (CFO-Air, Water) by the Karnataka State Pollution Control Board. It includes details about the license, its validity period, and its impact on the company. The document is a regulatory announcement about an environmental compliance approval, not a full report or financial statement. It is short (3575 characters) and serves as a formal notification to stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-13 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding a strategic investment decision made by the company's Board of Directors. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content details the approval of a strategic investment in another company, including specifics such as percentage acquisition, consideration amount, and regulatory approvals. This is a clear update on a capital/financing activity rather than a full financial report or earnings release. The document is about informing the market of a financing-related transaction (investment/acquisition of shares) and not about financial results or management commentary. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2025-11-12 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 87% confidence The document is a detailed “Outcome of the Board Meeting” under SEBI LODR Regulations 30 & 33, approving and enclosing the unaudited financial results for the quarter and half‐year ended September 30, 2025, complete with statement of profit & loss and balance sheet figures. It is far more than a brief earnings teaser and contains full interim financial statements. Therefore, it is an Interim/Quarterly Report rather than an earnings release or mere publication notice. H1 2026
2025-11-12 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 92% confidence The document is an official filing dated 12 November 2025 under SEBI LODR Regulations 30 & 33 announcing the outcome of a Board Meeting. It encloses the unaudited standalone and consolidated financial results for the quarter and half‐year ended 30 September 2025, complete with detailed income statement and balance sheet line items, plus the limited review report from auditors. The filing is more than a simple press release of highlights—it contains full interim financial statements for a portion of the fiscal year. Therefore, it constitutes an Interim/Quarterly Report rather than an earnings release (which would only provide key highlights) or a mere regulatory notice. H1 2026
2025-11-12 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.